Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vietnam Drug Authority Plan To Develop Local Drug Industry Is Mixed Bag For Foreign Drug Makers

This article was originally published in PharmAsia News

Executive Summary

The Vietnam Drug Administration has drafted a new master plan for developing its local drug industry that envisions supplying a majority of the country's demand for drugs from local drug makers by 2020-30

You may also be interested in...



Drug Price Hikes in Vietnam; Government Scrambles To Curb Prices And Ensure Drug Access

SHANGHAI - Prices of imported and locally made pharmaceutical products are on the rise in Vietnam, particularly in Hanoi and Ho Chi Minh City, largely due to a devalued currency, and the government is analyzing ways to step in to ensure access to medicines

Vietnam's Drug Regulators Call For Reduced Dependence On Pharmaceutical Imports

SHANGHAI - The Drug Administration of Vietnam is trying to work out a new strategy to cut the nation's dependence on imports of pharmaceuticals

Beyond BRIC: 'Pharmerging' Markets Loom If Pharma Is To Expand, IMS Study Says

Drug makers need to more aggressively target so-called "pharmerging" markets - but not just the usual suspects. Brazil, Russia, India and China remain highly important, but in a March 16 report, IMS Health predicts that 17 countries, in total, will contribute 48 percent of annual market growth in 2013, up from 37 percent last year

Latest Headlines
See All
UsernamePublicRestriction

Register

SC078056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel